Enveric Biosciences's total assets for Q1 2026 were $5.52M, an increase of 8.35% from the previous quarter. ENVB total liabilities were $460.68K for the fiscal quarter, a -49.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.